We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.1B
AUM Growth
+$1.98B
Cap. Flow
+$1.34B
Cap. Flow %
8.3%
Top 10 Hldgs %
18.52%
Holding
1,899
New
351
Increased
456
Reduced
282
Closed
805

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$260M
2
BABA icon
Alibaba
BABA
+$229M
3
GILD icon
Gilead Sciences
GILD
+$168M
4
BA icon
Boeing
BA
+$151M
5
ABT icon
Abbott
ABT
+$148M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$306M
2
UNH icon
UnitedHealth
UNH
+$244M
3
VMC icon
Vulcan Materials
VMC
+$146M
4
PEP icon
PepsiCo
PEP
+$98.4M
5
ELV icon
Elevance Health
ELV
+$96.5M

Sector Composition

Rank Sector Weight
1 Healthcare 27.6%
2 Technology 15.66%
3 Consumer Discretionary 13.93%
4 Industrials 11.16%
5 Communication Services 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNC icon
1601
Tennant Co
TNC
$1.26B
– –
-1,365
Closed -$85K
TNET icon
1602
TriNet
TNET
$3.14B
– –
-162,925
Closed -$9.73M
TNL icon
1603
Travel + Leisure Co
TNL
$4.7B
– –
-2,300
Closed -$93K
TPB icon
1604
Turning Point Brands
TPB
$1.74B
– –
-2
Closed –
TPIC
1605
DELISTED
TPI Composites
TPIC
– –
-78,782
Closed -$2.25M
TPR icon
1606
Tapestry
TPR
$32.8B
– –
-213,963
Closed -$6.95M
TR icon
1607
Tootsie Roll Industries
TR
$2.98B
– –
-101
Closed -$3K
TRNO icon
1608
Terreno Realty
TRNO
$7.49B
– –
-2,318
Closed -$97K
TRNS icon
1609
Transcat
TRNS
$871M
– –
-1,545
Closed -$36K
TROX icon
1610
Tronox
TROX
$1.04B
– –
-79,941
Closed -$1.05M
TRTX
1611
TPG RE Finance Trust
TRTX
$618M
– –
-374,457
Closed -$7.34M
TRV icon
1612
Travelers Companies
TRV
$80.2B
– –
-2,900
Closed -$398K
TSLA icon
1613
Tesla
TSLA
$1.3T
– –
-9,945
Closed -$186K
TSLX icon
1614
Sixth Street Specialty
TSLX
$1.81B
– –
-700
Closed -$14K
TTE icon
1615
TotalEnergies
TTE
$190B
– –
-13,176
Closed -$733K
TUSK icon
1616
Mammoth Energy Services
TUSK
$163M
– –
-6,346
Closed -$106K
TVTX icon
1617
Travere Therapeutics
TVTX
$5.78B
– –
-1,062
Closed -$24K
TWO
1618
Two Harbors Investment
TWO
$1.27B
– –
-3,815
Closed -$206K
TYL icon
1619
Tyler Technologies
TYL
$12.8B
– –
-2,457
Closed -$503K
UDR icon
1620
UDR
UDR
$12.3B
– –
-12,106
Closed -$551K
UE icon
1621
Urban Edge Properties
UE
$2.73B
– –
-1,100
Closed -$21K
UGP icon
1622
Ultrapar
UGP
$6.54B
– –
-820
Closed -$5K
UL icon
1623
Unilever
UL
$136B
– –
-356
Closed -$23K
ULBI icon
1624
Ultralife
ULBI
$106M
– –
-3,500
Closed -$36K
UMH
1625
UMH Properties
UMH
$1.36B
– –
-34,442
Closed -$485K
63 64
65
66 67

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2019 Portfolio in Review

As of Q2 2019, Marshall Wace North America held 1,899 positions worth $16.1B, up 14% from $14.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Marshall Wace North America deployed $1.34B of net new capital in Q2 2019, opening 351 new positions and adding to 456 existing holdings. Its largest new stake was Abbott: 1,884,363 shares worth $158M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Pfizer, an estimated $306M trimmed.

  • Marshall Wace North America's largest Q2 2019 buy was Abbott: 1,884,363 shares worth $158M.
  • Marshall Wace North America added most to Meta Platforms (Facebook) in Q2 2019, an estimated $260M increase.
  • Marshall Wace North America's biggest Q2 2019 reduction was Pfizer, cutting an estimated $306M.
  • Marshall Wace North America fully exited UnitedHealth in Q2 2019, selling an estimated $244M.
  • Marshall Wace North America's ten largest holdings make up 19% of its $16.1B portfolio in Q2 2019.
  • Marshall Wace North America opened 351 new positions and closed 805 in Q2 2019.
  • Marshall Wace North America's portfolio value rose 14% quarter-over-quarter to $16.1B.

Based on Marshall Wace North America's 13F filing for Q2 2019, filed 14 Aug 2019.